The Swiss medical technology company obviously is preparing for an IPO next year.
The Reuters news agency reported on Monday night, quoting circles. Thus, the public registration of the company located in Castel San Pietro in Ticino could take place in the spring.
The company has empowered Credit Suisse and Morgan Stanley as leading organizations – JPMorgan and UBS are also involved. At present, only a minority of shares will have to be sold to investors, he said.
The Medacta orthopedic implant manufacturer employs about 930 employees and is expected to sell around 300 million francs. The company specializes in knee and spine implants. Medacta is headed by founder Alberto Siccardi.